Puma Biotechnology
PBYI
PBYI
150 hedge funds and large institutions have $210M invested in Puma Biotechnology in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 132 → 150 (+18)
1.86% more ownership
Funds ownership: 68.28% → 70.14% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
150
Holding in Top 10
1
Calls
$699K
Puts
$2K
Top Buyers
| 1 | +$2.97M | |
| 2 | +$2.85M | |
| 3 | +$1.81M | |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$1.55M |
| 5 |
RWM
Ritholtz Wealth Management
New York
|
+$1.19M |
Top Sellers
| 1 | -$3.79M | |
| 2 | -$2.96M | |
| 3 | -$1.32M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.06M |
| 5 |
Universal-Beteiligungs- und Servicegesellschaft
Frankfurt Am Main,
Germany
|
-$845K |
